Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

4basebio announces spin-off of its DNA business
September 2020
EDIT CONNECT

SHARING OPTIONS:

HEIDELBERG, Germany & CAMBRIDGE, U.K.—Following a strategic review, 4basebio AG (formerly Expedeon AG) has announced its intention to commence a process to spin off its whole operating business—namely the genomics and DNA manufacturing business, which includes 4basebio SLU and 4basebio Ltd.
 
Subject to an ongoing legal and tax review, a spin-off of the business into a separate company is intended which shall have its corporate seat in the United Kingdom and be listed on the Alternative Investment Market (AIM), a submarket of the London Stock Exchange market.
 
As part of this, 4basebio is considering retaining a significant minority stake in the new entity and distributing the remaining shares to its existing shareholders.
 
The management board of 4basebio AG would join the board of the spin-off and assume responsibility for the day-to-day operation of this organization.
 
The intention is to complete this process by the end of 2020.
 
Code: E082029

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.